benzydamine has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coletta, I; Guglielmotti, A; Landolfi, C; Mantovani, A; Milanese, C; Pinza, M; Polenzani, L; Sironi, M; Soldo, L; Vecchi, A | 1 |
| Fonseca, AF; Mårdh, PA; Martinez-De-Oliveira, J; Pina-Vaz, C; Rodrigues, AG; Sansonetty, F | 1 |
2 other study(ies) available for benzydamine and Candidiasis
| Article | Year |
|---|---|
Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzydamine; Candidiasis; Chemokine CCL2; Female; Humans; Ibuprofen; Lymphocytes; Naproxen; Tumor Necrosis Factor-alpha; Vaginitis | 1997 |
Antifungal activity of local anesthetics against Candida species.
Topics: Agar; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Benzydamine; Bupivacaine; Candida; Candidiasis; Cell Membrane Permeability; Colony Count, Microbial; Female; Flow Cytometry; Humans; Lidocaine; Microbial Sensitivity Tests; Microscopy, Electron; Microscopy, Fluorescence; Time Factors | 2000 |